Relating to medication designated for treatment of respiratory distress on public and private school campuses, as well as institutions of higher education. Specifically:

• Schools may adopt and implement a policy regarding medication for respiratory distress; refer to the following Sections of this Bill:
  • Section 2: Definition of “Medication for Respiratory Distress;”
  • Section 6: Maintenance and Administration of Epinephrine Auto-Injectors, and Medication for Respiratory Distress;
  • Section 7: Report on Administering Medication for Respiratory Distress;
  • Section 8: Training;
  • Section 10: Prescription of Epinephrine Auto-Injectors and Medication for Respiratory Distress;
  • Section 11: Notice to Parents; and
  • Section 12: Immunity from Liability.
• Training required for each school district, open-enrollment charter school, and private school that adopts a policy; refer to the following Sections of this Bill:
  • Section 2: Definition of “medication for respiratory distress,”
  • Section 4: Advisory Committee Duties, and
  • Section 8: Training.
• Notification of parents to schools and schools to parents; refer to the following Sections of this Bill:
  • Section 2: Definition of “medication for respiratory distress,”
  • Section 6: Maintenance and Administration of Epinephrine Auto-Injectors, and Medication for Respiratory Distress;
  • Section 11: Notice to Parents; and
  • Section 12: Immunity from Liability.

Open-enrollment charter schools should review the following Sections of this Bill:

• Section 2: Definition of “Medication for Respiratory Distress;”
• Section 4: Advisory Committee Duties;
• Section 6: Maintenance and Administration of Epinephrine Auto-Injectors, and Medication for Respiratory Distress;
• Section 7: Report on Administering Medication for Respiratory Distress;
• Section 8: Training;
• Section 10: Prescription of Epinephrine Auto-Injectors and Medication for Respiratory Distress;
• Section 11: Notice to Parents; and
• Section 12: Immunity from Liability.

Institutions of higher education should review the following Sections of this Bill:

• Section 2: Definition of “Medication for Respiratory Distress;”
• Section 4: Advisory Committee Duties;
• Section 12: Immunity from Liability.